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We determined the molecular characteristics of methi-
cillin-resistant staphylococci from animals and staff at a
small animal and equine hospital. Methicillin-resistant
Staphylococcus aureus (MRSA) identical to human
EMRSA-15 was found in dogs and hospital staff. In con-
trast, 5 distinct MRSA strains were isolated from horses but
not from hospital staff.
M
ethicillin-resistant  Staphylococcus aureus (MRSA)
is among the most important causes of human
healthcare associated infections. MRSA has also caused
infections in dogs (1,2), and cases of human-to-dog trans-
mission of MRSA in which dogs have acted as reservoirs
for reinfection have been reported (3,4). MRSAand methi-
cillin-resistant, coagulase-negative staphylococci (MR-
CNS) have also been reported in horses (5), including
outbreaks in equine hospitals (6). In these cases, MRSA
was thought to be of human origin (6); however, a
Japanese study could not definitively relate equine to
human MRSA with pulsed-field gel electrophoresis
(PFGE) (7). At a Canadian equine hospital and thorough-
bred farm, both horses and staff were positive for MRSA,
and 96% and 93% of isolates, respectively, were subtypes
of a rare Canadian MRSA-5 clone (8).
Horses, dogs, and cats in the community; animals treat-
ed at the University of Liverpool’s Small Animal Hospital
(SAH) and Philip Leverhulme Equine Hospital (PLEH);
and staff at those hospitals were screened for MRSA. The
molecular characteristics of MRSA in these populations
were investigated to determine the source and routes of
transmission. Animal samples were also screened for MR-
CNS.
The Study
Swabs were taken from the anterior nares of dogs,
horses, and staff; nasal surface of cats; perineum of dogs,
cats, and horses; and the neck skin surface of horses. All
diagnostic submissions from both of these hospitals were
screened for MRSA. Swab specimens were directly inocu-
lated onto mannitol salt agar (LabM, Bury, UK) with aztre-
onam (2 mg/L) and oxacillin resistance–screening agar
(Oxoid, Basingstoke, UK) and incubated at 37°C for <48
h. Staphylococci were identified by colony shape, Gram
stain, staphylase test (Oxoid), and API staph kit (MR-CNS
only) (bioMérieux, Basingstoke, UK). The disk-diffusion
method (Mast, Liverpool, UK) was used to determine the
susceptibility of all isolates to oxacillin, methicillin, gen-
tamicin, vancomycin, rifampicin, ciprofloxacin, co-tri-
moxazole, fusidic acid, and tetracycline, according to the
British Society for Antimicrobial Chemotherapy guide-
lines, by using S. aureus ATCC 26923, EMRSA-15, and
EMRSA-16 as controls (9).
Cell lysates of all methicillin-resistant staphylococci
were prepared as described previously (10). Cell lysates
were also prepared from 3 control strains, EMRSA-15,
EMRSA-16, and the Canadian epidemic strain, CMRSA-
5, previously found in horses and humans (8). The pres-
ence of the mecA gene was determined with polymerase
chain reaction (PCR) by using a modified method adapted
from Vanuffel et al. (11), with a conventional thermocy-
cler. PCR to detect the S. aureus femA gene was used to
confirm isolates as MRSA (12). For all MRSA and equine
MR-CNS isolates, the SCCmec cassette and the agr oper-
on were analyzed as described previously (13). All MRSA
isolates were screened for the gene encoding Panton-
Valentine leukocidin by using the method of Lina et al.
(14); a positive control for this reaction was provided by
the Scottish MRSA Reference Laboratory. Macro-
restriction of the genome and PFGE were conducted on all
MRSA isolates according to the protocol described by
Murchan et al. (15) and included on each gel with
EMRSA-15 and -16 and CMRSA-5.
Swabs taken from cats (n = 50) and dogs (n = 55) treat-
ed at the SAH and cats within the community
(February–March 2004) were negative for MRSA. One cat
was positive for methicillin-resistant staphylococci, and 4
dogs were positive for MR-CNS, all of which were con-
firmed by PCR to be carrying the mecA gene. However, 3
dogs with clinical infections (a joint infection in January
2004, pleuropneumonia in March 2004, and a wound
infection in June 2004) were positive for MRSAat the site
of infection. The dog with the joint infection was also pos-
itive for nasal and fecal carriage of MRSA; a student who
treated the dog had an MRSA-positive nasal swab in April
2004. Eleven staff provided nasal swabs, of which 2 were
positive for MRSA in January 2004 (Table). All MRSA
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*University of Liverpool, Leahurst, United Kingdom; and Royal
Liverpool University Hospital, Liverpool, United Kingdom isolates were resistant to ciprofloxacin but sensitive to all
other antimicrobial drugs tested. All MRSA isolates were
positive for the mecA and femA genes, carried the SCCmec
type IV cassette, and were agr operon group 1 strains but
were negative for pvl genes. PFGE showed that the human
and dog clinical MRSA isolates were identical to the
human epidemic strain, EMRSA-15 (Figure).
Of the 105 horses sampled, MRSA was isolated only
from horses at PLEH. Of the 67 horses sampled at PLEH,
11 were positive (16%) for carriage and 3 had MRSA-
associated clinical infections (pleuropneumonia, chronic
septic arthritis, and chronic dermatitis). None of the iso-
lates submitted from 12 staff members at the equine hospi-
tal were positive for MRSA. The horse MRSA isolates
were resistant to gentamicin (100%), rifampicin (80%),
ciprofloxacin (78%), fusidic acid (69%), co-trimoxazole
(50%), and tetracycline (50%) but not to vancomycin. All
MRSAisolates were positive for the mecA and femA genes
and were agr group 1, except 2 that were agr group 2, but
all were negative for the pvl genes. Like the human and
dog isolates, all horse MRSA isolates except 3 (1 isolate
had a variant of type II or III, and 2 isolates repeatedly
failed to give PCR products for SCCmec cassettes), carried
the SCCmec cassette type IV. MR-CNS was isolated from
19% of horses at the PLEH and 30% of horses in the com-
munity. All horse MR-CNS isolates (including those from
PLEH) had different SCCmec cassettes than the MRSA
isolates, and their banding patterns did not fully corre-
spond to any of the known cassette types, giving a 209-bp
band (types II and III) and a further band of 495 bp (type
I). Twelve MRSA isolates from 7 horses were selected for
PFGE based on differences in antibiogram and genes
detected by PCR. This analysis showed 5 distinct strains.
The same strain found in nasal samples, 1 skin sample
from 3 horses, and 1 MRSA strain from a clinical case-
patient were closely related to a nasal isolate from a differ-
ent horse. None of the horse MRSA strains were related to
EMRSA-15, EMRSA-16, or CMRSA-5 as demonstrated
in the Figure.
Conclusions
This study documents MRSA transmission between
humans and dogs; the same strain was found in 3 staff
members and 3 dogs, all identical to the predominant
human epidemic strain EMRSA-15. Two staff members
and a student who treated 1 dog were positive for the same
MRSA strain. Furthermore, MRSA was associated with
clinical disease in 2 other dogs some months later; this
finding could suggest a cycle of transmission between staff
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Figure. Dendrogram showing the pulsed-field gel electrophoresis
patterns after macrorestriction of genomic DNA with SmaI of
methicillin-resistant Staphylococcus aureus (MRSA) isolates from
the small animal hospital (SAH) and the equine hospital. The dog
and human isolates (SAH staff) were identical to the UK major epi-
demic strain EMRSA-15, and the equine MRSA isolates (5 distinct
profiles) were unrelated to EMRSA-15, EMRSA-16, or CMRSA-5.
Profiles were analyzed with Molecular Analyst software (Applied
Maths, Inc., Sint-Martens-Latem, Belgium) by unweighted pair
grouping by mathematical averaging clustering method with a 2%
tolerance window and using the Dice coefficient.
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and animals. However, the origin of MRSAin the first dog
is unknown and could have originated in either staff or the
dog in question, with dog-to-human transmission or vice
versa. This study suggests that dogs can act as reservoirs of
MRSA, which can pose a public health risk to owners and
veterinary staff, as well as limit the options for antimicro-
bial drug treatment of MRSAinfections. Staff in veterinary
hospitals could have an increased risk of carrying MRSA
because of contact with infected animals and antimicrobial
drugs in their work environment.
Contrary to SAH results of this study and previous
work in Canada, no evidence was seen of MRSAtransmis-
sion between staff and horses at PLEH, nor were any iso-
lates related to the predominant UK human epidemic
strains or CMRSA-5. However, 5 different horse MRSA
strains were identified with unknown sources. The fact that
different SCCmec cassettes were found in horse MR-CNS
isolates than in MRSAisolates does not suggest that methi-
cillin resistance had transferred from MR-CNS to MRSA.
Furthermore, the prevalence of MR-CNS in horses in the
community is almost double that which was found in
horses at PLEH. This could suggest that MR-CNS may
compete well with methicillin-sensitive CNS in an envi-
ronment where antimicrobial drugs are not present. These
results imply that MRSA is present in the general horse
population and may represent a reservoir of new or rare
MRSA strains that could be transmitted to humans.
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